A3P Biomedical AB (publ)
Advanced blood test for early, accurate prostate cancer detection.
Yleiskatsaus
- 20–49
- Työntekijät
- 2.5–5milj SEK
- Liikevaihto
- 2020
- Perustettu
Avainpäättäjät
David Rosén
Chief Executive Officer
Cecilia Edström
Board Member and acting Chief Financial Officer
Ola Steinberg
Chief Executive Officer
Maria Jansson
VP Operations, Quality Assurance & Regulatory Affairs
+8 lisää yhteystietoja Funnelfeedrissä
Kuvaus
A3P Biomedical AB (publ) is a specialized medical technology company focused on improving prostate cancer diagnostics globally. Their flagship product is the Stockholm3 blood test, which offers early detection and precise risk stratification for aggressive prostate cancer. This advanced test utilize...